Evidence mapPaperPMID 34590446Full record

ReviewAdvanced biology2021

Formation and Cellular Impact of Cholesterol Crystals in Health and Disease.

Yvonne Baumer, Sara G McCurdy, William A Boisvert

Open access · greenAbstract readReview
In one paragraph

Review in Advanced biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Yvonne BaumerSocial Determinants of Obesity and Cardiovascular Risk Laboratory, National Heart, Lung, and Blood Institute, Building 10, 10 Center Drive, Bethesda, MD, 20814, USA.
Sara G McCurdyDept. of Medicine, University of California San Diego, 9500 Gilman Street, La Jolla, CA, 92093, USA.
William A BoisvertCenter for Cardiovascular Research, University of Hawaii, 651 Ilalo Street, Honolulu, HI, 96813, USA.ORCID 0000-0003-2574-9176
National Heart Lung and Blood Institute · USUniversity of California San Diego · USUniversity of Hawaii System · US

Funding

Anti-inflammatory Cytokines in AtherosclerosisR01HL075677 · BRIGHAM AND WOMEN'S HOSPITAL · 2005 to 2005
$409k
NHLBI NIH HHS R01 HL075677
6 · The paper itself

Abstract

Cholesterol crystals (CCs) were first discovered in atherosclerotic plaque tissue in the early 1900 and have since been observed and implicated in many diseases and conditions, including myocardial infarction, abdominal aortic aneurism, kidney disease, ocular diseases, and even central nervous system anomalies. Despite the widespread involvement of CCs in many pathologies, the mechanisms involved in their formation and their role in various diseases are still not fully understood. Current knowledge concerning the formation of CCs, as well as the molecular pathways activated upon cellular exposure to CCs, will be explored in this review. As CC formation is tightly associated with lipid metabolism, the role of cellular lipid homeostasis in the formation of CCs is highlighted, including the role of lysosomes. In addition, cellular pathways and processes known to be affected by CCs are described. In particular, CC-induced activation of the inflammasome and production of reactive oxygen species, along with the role of CCs in complement-mediated inflammation is discussed. Moreover, the clinical manifestation of embolized CCs is described with a focus on renal and skin diseases associated with CC embolism. Lastly, potential therapeutic measures that target either the formation of CCs or their impact on different cell types and tissues are highlighted.

Indexed as

CholesterolPlaque, AtheroscleroticComplement System ProteinsHumansInflammasomesInflammation MediatorsCholesterolComplement System ProteinsInflammasomesInflammation Mediatorsatherosclerosiscardiovascular diseasecholesterol crystalsinflammasomeinflammationlysosome

Identifiers

PMID34590446
PMCPMC11055929
OpenAlexW3202319128

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.